These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23382159)

  • 21. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
    Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
    J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.
    Happi CT; Gbotosho GO; Folarin OA; Sowunmi A; Hudson T; O'Neil M; Milhous W; Wirth DF; Oduola AM
    Antimicrob Agents Chemother; 2009 Mar; 53(3):888-95. PubMed ID: 19075074
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of
    Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
    Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
    Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
    Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
    Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
    Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
    Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms.
    Malmberg M; Ferreira PE; Tarning J; Ursing J; Ngasala B; Björkman A; Mårtensson A; Gil JP
    J Infect Dis; 2013 Mar; 207(5):842-7. PubMed ID: 23225895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
    Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
    Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
    Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD
    Malar J; 2009 May; 8():107. PubMed ID: 19454000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
    Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK
    Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.
    Dieye B; Affara M; Sangare L; Joof F; Ndiaye YD; Gomis JF; Ndiaye M; Mbaye A; Diakite M; Sy N; Mbengue B; Deme AB; Daniels R; Ahouidi AD; Dieye T; Abdullahi A; Doumbia S; Ndiaye JL; Diarra A; Ismaela A; Coulibaly M; Welty C; Ngwa AA; Shaffer J; D'Alessandro U; Volkman SK; Wirth DF; Krogstad DJ; Koita O; Nwakanma D; Ndiaye D
    Am J Trop Med Hyg; 2016 Nov; 95(5):1054-1060. PubMed ID: 27549635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia.
    Yohannes AM; Teklehaimanot A; Bergqvist Y; Ringwald P
    Am J Trop Med Hyg; 2011 Jan; 84(1):137-40. PubMed ID: 21212216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.
    Sisowath C; Ferreira PE; Bustamante LY; Dahlström S; Mårtensson A; Björkman A; Krishna S; Gil JP
    Trop Med Int Health; 2007 Jun; 12(6):736-42. PubMed ID: 17550470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum.
    Mungthin M; Khositnithikul R; Sitthichot N; Suwandittakul N; Wattanaveeradej V; Ward SA; Na-Bangchang K
    Am J Trop Med Hyg; 2010 Nov; 83(5):1005-9. PubMed ID: 21036827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.